Sebastian Hofmann

Managing Director at Fresenius Biotech GmbH - Rapperswil-Jona, St. Gallen, Switzerland

Sebastian Hofmann's Contact Details
HQ
(781) 373-3766
Location
Bavaria,Germany
Company
Fresenius Biotech GmbH
Sebastian Hofmann's Company Details
Fresenius Biotech GmbH logo, Fresenius Biotech GmbH contact details

Fresenius Biotech GmbH

Rapperswil-Jona, St. Gallen, Switzerland • 109 Employees
Biotechnology

Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology. Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.

Details about Fresenius Biotech GmbH
Frequently Asked Questions about Sebastian Hofmann
Sebastian Hofmann currently works for Fresenius Biotech GmbH.
Sebastian Hofmann's role at Fresenius Biotech GmbH is Managing Director.
Sebastian Hofmann's email address is ***@neovii.com. To view Sebastian Hofmann's full email address, please signup to ConnectPlex.
Sebastian Hofmann works in the Biotechnology industry.
Sebastian Hofmann's colleagues at Fresenius Biotech GmbH are Mahmoud Hefny, Katerina Maskova, Esat Yuce, Marta Gonzalez, Tansu Cinar, Marina Quick, Claudio Carini and others.
Sebastian Hofmann's phone number is (781) 373-3766
See more information about Sebastian Hofmann